BioNTech continued to grow its oncology business by agreeing to buy fellow German biotech CureVac for $1.25 billion in a deal that combines two of the world's leaders in mRNA treatments.

BioNTech continued to grow its oncology business by agreeing to buy fellow German biotech CureVac for $1.25 billion in a deal ...

Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies ...

The global pharmaceutical lipids market is valued at USD 5.4 billion in 2025, registering Y-o-Y growth of 5.1% attaining market value of USD 9.0 billion by 2035. The revenue generated by allergy ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting white blood cells, which play a crucial role in coordinating the immune ...

Scientists found a way to make the HIV virus visible, potentially laying the groundwork for ways to banish it from the body ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

Scientists behind a world-first gene therapy reveal how they teamed up with experts across academia and industry to produce a ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration ...